ST凯利：9月27日召开董事会会议

Group 1 - ST凯利 held its 11th meeting of the 6th Board of Directors on September 27, 2025, discussing the proposal for the reappointment of the financial audit institution [1] - For the year 2024, ST凯利's revenue composition is as follows: 56.82% from medical device manufacturing, 26.48% from instrument disinfection services, 14.48% from medical device trading, and 2.21% from other businesses [1] - As of the report date, ST凯利's market capitalization is 4.2 billion yuan [2]